Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Melvyn R. Danzig"'
Publikováno v:
Allergy and Asthma Proceedings. 30:270-276
Onset of action is recognized as an important pharmacologic property of allergic rhinitis (AR) medications. This study was designed to evaluate the onset of action of loratadine/montelukast (L/M; 10 mg/10 mg) versus placebo in subjects with ragweed-i
Autor:
Miyoshi Fujita, Il-Whan Choi, Yumiko Kamada, R. Seitz, Takahito Chiba, Toshiro Takai, A.R. Lorenz, Ursula Smole, Yuen Shan Lee, Ka Hou Chu, Ming Chiu Fung, Melvyn R. Danzig, Shigaku Ikeda, Suhn-Young Im, Xiao Ling Wang, Catherine R. Weiler, Wing Yee Kung, Hendra Gunawan, Christof Ebner, Ya-Hui Chuang, Joseph H. Butterfield, Ronald B. Turner, Robert Anolik, Sara H. Bengtson, Patrick S.C. Leung, S. Vieths, Jae-Hong Kim, Wataru Ito, Hikari Kato, Arihiko Kanehiro, Robert B. Sarnoff, Hiroyuki Kayaba, Eric J. Schenkel, Gavin R. Jenkins, Santosh Varghese, Bor-Luen Chiang, Kazutoshi Yamaguchi, Masahide Takeda, Chi Yan Tang, Seiji Kamijo, Hern-Ku Lee, Hye-Jin You, Hae-Kyoung Kim, Junichi Chihara, Shigeharu Ueki, Heimo Breiteneder, Sandra C. Christiansen, D. Lüttkopf, Jack M. Gwaltney, Christian Radauer, Robert A. Nathan, Hyun-Mi Ko, Ko Okumura, Davis Gates, J. Eddleston, Bruce L. Zuraw, Hideoki Ogawa, Nam-In Kang, Merima Bublin
Publikováno v:
International Archives of Allergy and Immunology. 147:I-IV
Autor:
Melvyn R. Danzig, Paul Stryszak, William E. Berger, Carlos E. Baena-Cagnani, Sandra E. Gurné, Lawrence M. DuBuske, Richard R. Lorber
Publikováno v:
International Archives of Allergy and Immunology. 130:307-313
Background: Asthma and seasonal allergic rhinitis (SAR) are recognized as manifestations of a single airway disease. Desloratadine has demonstrated efficacy in treating SAR symptoms, including nasal obstruction. Methods: Safety and efficacy of deslor
Autor:
Richard R. Lorber, William W. Busse, Ger Rikken, Andrew Pedinoff, Melvyn R. Danzig, Guy A. Settipane, B.Lauren Charous, Eli O. Meltzer, S. James Zinreich, Anjuli Nayak
Publikováno v:
Annals of Allergy, Asthma & Immunology. 89:271-278
Background Mometasone furoate nasal spray (MFNS) 400 μg, twice daily, as adjunctive treatment with oral antibiotic significantly improved symptoms of recurrent rhinosinusitis. Objective To evaluate the effectiveness and safety of MFNS 200 μg, twice
Autor:
Tim Keith, Jason Simon, Brooke Hayward, Alison Walsh, Dana Torrey, Cuss Francis M, Joann Dubois, Rene Gibson, Shelby P. Umland, Michelle Thackston, John W. Holloway, Kristina Allen, Ziying Liu, Paul Van Eerdewegh, Michael Fitzgerald, Joyce McKenny, Yun Feng, S. Rorke, Richard G. Del Mastro, Ron Adair, Hui Huang, Mei Wang, Youssef Benchekroun, Lisa Saracino, Josée Dupuis, Alex Pedan, Sunil Pandit, Melvyn R. Danzig, Susan P. Manning, Stephen T. Holgate, Karen Braunschweiger, Randall D. Little, Joanne B. Clough, Robert W. Egan, Neva J. Capparell, Kathy Falls, Colleen Folz, Alicia Bawa
Publikováno v:
Nature. 418:426-430
Asthma is a common respiratory disorder characterized by recurrent episodes of coughing, wheezing and breathlessness. Although environmental factors such as allergen exposure are risk factors in the development of asthma, both twin and family studies
Autor:
Eli O. Meltzer, Melvyn R. Danzig, Richard R. Lorber, S. James Zinreich, William W. Busse, B.Lauren Charous
Publikováno v:
Journal of Allergy and Clinical Immunology. 106:630-637
Background: Intranasal glucocorticoids are effective in the treatment of allergic rhinitis. Their effectiveness as an anti-inflammatory adjunct in the treatment of acute recurrent sinusitis has not been adequately established in a controlled clinical
Autor:
Judy E. Harrison, David I. Bernstein, Charles H. Banov, Edwin A. Bronsky, Lawrence J. Sholler, Robert R. Berkowitz, John W. Georgitis, Melvyn R. Danzig, Richard R. Lorber, Harold B. Kaiser, William W. Stricker, Louis M. Mendelson, Anthony R. Rooklin
Publikováno v:
American Journal of Therapeutics. 5:245-252
The objective of this study was to compare the efficacy and safety of Claritin-D 24 Hour (once daily) with that of Claritin-D 12 Hour (twice daily) and placebo in the treatment of patients with seasonal allergic rhinitis (SAR). In this double-blind,
Autor:
Michael R. Spence, Michael F. Rein, Lorraine duBouchet, Melvyn R. Danzig, William M. McCormack
Publikováno v:
Sexually Transmitted Diseases. 24:156-160
Trichomonas vaginalis is a common vaginal pathogen. Oral metronidazole is the drug of choice for the treatment of trichomoniasis. Oral metronidazole, however, may cause unpleasant side effects and is contraindicated during the first trimester of preg
Autor:
Wiestaw Sutkowski, Mariola Śliwińska-Kowalska, Wiktor Wesotowski, Melvyn R. Danzig, Marek L. Kowalski
Publikováno v:
American Journal of Rhinology. 8:231-236
In order to characterize the effect of metabisulfite (MBS) on human nasal mucosa, in 10 healthy, non-atopic subjects and in six patients with atopic rhinitis, 50 mg/mL and 100 mg/mL solutions of MBS were sprayed into both nostrils. Clinical symptoms
Publikováno v:
Allergy and asthma proceedings. 31(6)
The safety of loratadine (second-generation antihistamine) and montelukast (leukotriene receptor antagonist) as monotherapies is well documented. Safety of the fixed-dose, single-tablet therapy loratadine/montelukast (L/M; SCH 445761, containing lora